Multiomics data has revolutionized immuno-oncology studies by facilitating both populational and personalized facets of treatment planning. Here the authors review current computational tools, stratified into four ‘paradigms’, for analyzing multiomics data and facilitating optimization of cancer therapy.
- Bingrui Li
- Ruihan Luo
- Xiaobo Zhou